Meryl Selig, B-Cell Lymphoma
Meryl Selig has had a unique Stanford journey. She began as a patient volunteer and then became a patient after being diagnosed with B-cell lymphoma. She underwent chemotherapy and enrolled in a clinical trial for a novel CAR-T cell treatment. She sat down with the Stanford Cancer Institute team to share her transformative experience.